Evidence map›Paper›PMID 8816452›Full record

ArticleMolecular and cellular biology1996

Functional properties of p54, a novel SR protein active in constitutive and alternative splicing.

W J Zhang, J Y Wu

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. SR proteins in cancer: function, regulation, and small inhibitor.Cellular & molecular biology letters · 2024
    Review
  4. Review
  5. Article
  6. RNA splicing: a dual-edged sword for hepatocellular carcinoma.Medical oncology (Northwood, London, England) · 2022
    Review
  7. Article
  8. Article
  9. NONO and tumorigenesis: More than splicing.Journal of cellular and molecular medicine · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

W J ZhangDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Y Wu
University of Washington · US

Funding

Pre-mRNA Splicing Defects and Retinal DegenerationR01EY014576 · NEI · VANDERBILT UNIVERSITY · PI WU, JANE Y · 2004 to 2008
$1.8M
Slit Signaling in Breast CancerR01CA114197 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JANE Y · 2006 to 2010
$1.3M
Alternative splicing regulation of caspase-2 geneR01GM070967 · NIGMS · VANDERBILT UNIVERSITY · PI WU, JANE Y · 2005 to 2008
$939k
FUNCTION OF MAMMALIAN PREMRNA SPLICING FACTORSR01GM053945 · NIGMS · WASHINGTON UNIVERSITY · PI WU, JANE Y · 1996 to 2000
$206k
NCI NIH HHS R01 CA114197NEI NIH HHS R01 EY014576NIGMS NIH HHS R01 GM070967NIGMS NIH HHS R01 GM53945
6 · The paper itself

Abstract

The p54 protein was previously identified by its reactivity with an autoantiserum. We report here that p54 is a new member of the SR family of splicing factors, as judged from its structural, antigenic, and functional characteristics. Consistent with its identification as an SR protein, p54 can function as a constitutive splicing factor in complementing splicing-deficient HeLa cell S100 extract. However, p54 also shows properties distinct from those of other SR family members, p54 can directly interact with the 65-kDa subunit of U2 auxiliary factor (U2AF65), a protein associated with the 3' splice site. In addition, p54 interacts with other SR proteins but does not interact with the U1 small nuclear ribonucleoprotein U1-70K or the 35-kDa subunit of U2 auxiliary factor (U2AF35). This protein-protein interaction profile is different from those of prototypical SR proteins SC35 and ASF/SF2, both of which interact with U1-70K and U2AF35 but not with U2AF65. p54 promotes the use of the distal 5' splice site in E1A pre-mRNA alternative splicing, while the same site is suppressed by ASF/SF2 and SC35. These findings and the differential tissue distribution of p54 suggest that this novel SR protein may participate in regulation of alternative splicing in a tissue- and substrate-dependent manner.

Indexed as

Alternative SplicingAmino Acid SequenceAnimalsBlotting, NorthernCell LineDNA, ComplementaryEpitopesGene ExpressionGenetic Complementation TestHeLa CellsHumansMolecular Sequence DataNuclear ProteinsNucleopolyhedrovirusesOrgan SpecificityRNA PrecursorsDNA, ComplementaryEpitopesNuclear ProteinsRNA PrecursorsSerine-Arginine Splicing FactorsSfrs11 protein

Identifiers

PMID8816452
PMCPMC231539
OpenAlexW1890830291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.